Neurol (Alprazolam)

Alprazolam, the active ingredient in Neurol, is a benzodiazepine presented as an oral tablet for oral use. It is prescribed to manage anxiety disorders and panic disorder in adult patients.\n\nGNH India supplies Neurol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Alprazolam belongs to the benzodiazepine class and is used to treat conditions related to excessive central nervous system excitation.\n\n- Anxiety disorders: reduces excessive worry and tension, helping patients regain functional daily activity.\n- Panic disorder: decreases the frequency and intensity of panic attacks, providing rapid symptom control.\n- Short‑term management of acute anxiety: offers quick relief of situational anxiety symptoms while longer‑term strategies are implemented.

Alprazolam may cause a range of adverse reactions, from mild to severe. Patients should be aware of both common and less frequent side effects.\n\nCommon Side Effects:\n- Drowsiness: feeling unusually sleepy or fatigued.\n- Dizziness: light‑headed sensation, especially when standing quickly.\n- Impaired coordination: reduced motor control or clumsiness.\n- Memory disturbances: difficulty recalling recent events.\n- Gastrointestinal upset: nausea or abdominal discomfort.\n\nSerious or Rare Side Effects:\n- Respiratory depression: slowed or shallow breathing, especially with other depressants.\n- Severe allergic reaction: rash, itching, swelling, or difficulty breathing.\n- Mood changes: depression, suicidal thoughts, or aggression.\n- Dependence or withdrawal: physical or psychological reliance after prolonged use.

Before initiating therapy with alprazolam, consider the following safety measures.\n\n- Assess medical history: evaluate for respiratory disorders, liver impairment, or a history of substance abuse.\n- Pregnancy and lactation: avoid use in pregnancy (Category D) and breastfeeding unless benefits outweigh risks.\n- Concomitant CNS depressants: limit use with alcohol, opioids, or other sedatives to reduce respiratory depression risk.\n- Elderly patients: start at the lowest effective dose and monitor for falls or confusion.\n- Discontinuation: taper gradually under medical supervision to prevent withdrawal symptoms.\n- Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Alprazolam can interact with several drug classes, altering its efficacy or safety profile.\n\nMajor Interactions (Avoid):\n- Opioids: combined use may cause profound respiratory depression.\n- Alcohol: additive CNS depression leading to excessive sedation.\n- Barbiturates: may enhance sedative effects and increase overdose risk.\n- Certain antifungals (e.g., ketoconazole): can raise alprazolam plasma levels.\n- Macrolide antibiotics (e.g., erythromycin): may increase drug concentration.\n\nModerate Interactions (Monitor Closely):\n- CYP3A4 inhibitors (e.g., fluoxetine, grapefruit juice): may require dose adjustment.\n- Antidepressants (e.g., SSRIs): monitor for enhanced sedation.\n- Antihistamines: may increase drowsiness.\n- Antihypertensives: watch for additive hypotensive effects.\n- Oral contraceptives: possible alteration of hormone levels.